Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey I Shapiro

Showing results (31-40 of 277) with videos related to

Pageof 28
Sort By:
NPJ Breast Cancer|September 6, 2022
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancerConstantia Pantelidou, Heta Jadhav, Aditi Kothari, et al.
Gynecologic Oncology|July 18, 2025
The RAS-MEK-ERK pathway in low-grade serous ovarian cancerElizabeth H Stover, Elizabeth K Lee, Geoffrey I Shapiro, et al.
Cancer Research|December 20, 2007
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrionJing Deng, Takeshi Shimamura, Samanthi Perera, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphomaJames M Cleary, Scott Rodig, Paul M Barr, et al.
Cancer Chemotherapy and Pharmacology|June 4, 2010
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancerAnthony W Tolcher, Leonard J Appleman, Geoffrey I Shapiro, et al.
Heliyon|November 1, 2023
Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS methodZahra Talebi, Dominique A Garrison, Eric D Eisenmann, et al.
Cancer Research|November 13, 2003
Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activityJingrui Jiang, Christian B Matranga, Dongpo Cai, et al.
Oncotarget|September 1, 2018
Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in <i>KRAS</i>-mutant non-small cell lung cancerEric Haines, Ting Chen, Naveen Kommajosyula, et al.
Cancer Chemotherapy and Pharmacology|April 5, 2011
Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumorsPatricia LoRusso, Geoffrey I Shapiro, Herbert Hurwitz, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Defective Microhomology-Mediated End-joining in SMARCB1-Deficient TumorsGuangli Zhu, Shuhei Asada, Huy Nguyen, et al.
Pageof 28

Showing results (31-40 of 277) with videos related to

Sort By:
Pageof 28
NPJ Breast Cancer|September 6, 2022
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancerConstantia Pantelidou, Heta Jadhav, Aditi Kothari, et al.
Gynecologic Oncology|July 18, 2025
The RAS-MEK-ERK pathway in low-grade serous ovarian cancerElizabeth H Stover, Elizabeth K Lee, Geoffrey I Shapiro, et al.
Cancer Research|December 20, 2007
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrionJing Deng, Takeshi Shimamura, Samanthi Perera, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphomaJames M Cleary, Scott Rodig, Paul M Barr, et al.
Cancer Chemotherapy and Pharmacology|June 4, 2010
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancerAnthony W Tolcher, Leonard J Appleman, Geoffrey I Shapiro, et al.
Heliyon|November 1, 2023
Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS methodZahra Talebi, Dominique A Garrison, Eric D Eisenmann, et al.
Cancer Research|November 13, 2003
Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activityJingrui Jiang, Christian B Matranga, Dongpo Cai, et al.
Oncotarget|September 1, 2018
Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in <i>KRAS</i>-mutant non-small cell lung cancerEric Haines, Ting Chen, Naveen Kommajosyula, et al.
Cancer Chemotherapy and Pharmacology|April 5, 2011
Lack of food effect on single-dose pharmacokinetics of brivanib, and safety and efficacy following multiple doses in subjects with advanced or metastatic solid tumorsPatricia LoRusso, Geoffrey I Shapiro, Herbert Hurwitz, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Defective Microhomology-Mediated End-joining in SMARCB1-Deficient TumorsGuangli Zhu, Shuhei Asada, Huy Nguyen, et al.
Pageof 28